Imexpharm Corp
VN:IMP
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| VN |
I
|
Imexpharm Corp
VN:IMP
|
8.6T VND |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
930.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
256.9B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.2B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD |
Loading...
|
Market Distribution
| Min | -67 046.2% |
| 30th Percentile | 1.4% |
| Median | 4% |
| 70th Percentile | 9.8% |
| Max | 1 155.9% |
Other Profitability Ratios
Imexpharm Corp
Glance View
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Imexpharm Corp is 12.5%, which is below its 3-year median of 12.7%.
Over the last 3 years, Imexpharm Corp’s Net Margin has increased from 11.2% to 12.5%. During this period, it reached a low of 11.2% on Dec 31, 2022 and a high of 13.9% on Dec 31, 2023.
